Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Efficacy and Hemidiaphragmatic Paresis With Combined Suprascapular Nerve Block and PECS I Block Versus Interscalene Block in Arthroscopic Shoulder Surgery: A Randomized Non-Inferiority Trial

NCT07852754 is registered in ClinicalTrials.gov with Cansu Ofluoğlu as lead sponsor.

NCT NCT07852754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Efficacy and Hemidiaphragmatic Paresis With Combined Suprascapular Nerve Block and PECS I Block Versus Interscalene Block in Arthroscopic Shoulder Surgery: A Randomized Non-Inferiority Trial
Lead sponsor
Cansu Ofluoğlu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
May 1, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemidiaphragmatic paresis, postoperative pain